Moreover, a markedly higher CD8<sup>+</sup>PD-1<sup>+</sup>/CD4<sup>+</sup>PD-1<sup>+</sup> (PERLS) ratio was observed in patients who subsequently developed AML, particularly during the progression phase. The gene discussed is CD8A; the disease is acute myeloid leukemia.